Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects is a clinical trial[1].
Key Facts
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects is in the country of Japan[2].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's instance of is recorded as clinical trial[3].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's start time is recorded as +2006-02-17T00:00:00Z[4].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's end time is recorded as +2007-12-01T00:00:00Z[5].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's sponsor is recorded as GSK[6].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's main subject is recorded as hyperplasia[7].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's number of participants is recorded as {'unit': '1', 'amount': '+378'}[8].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's title is recorded as Clinical Evaluation of Dutasteride in Benign Prostatic Hyperplasia: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Comparative Study of GI198745 (Dutasteride) in Subjects With Benign Prostatic Hyperplasia.[9].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+50'}[10].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's ClinicalTrials.gov ID is recorded as NCT00368979[11].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's research intervention is recorded as dutasteride[12].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's clinical trial phase is recorded as phase III clinical trial[13].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's research site is recorded as GSK[14].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's research subject recruitment status is recorded as completed[15].
- Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects's study type is recorded as interventional study[16].